Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;25(6):761-8.
doi: 10.1016/j.coi.2013.09.016.

The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses

Review

The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses

Martin L Moore et al. Curr Opin Immunol. 2013 Dec.

Abstract

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection (LRI) and viral death in infants. RSV disease in infants is characterized by epithelial desquamation, neutrophilic bronchiolitis and pneumonia and obstructive pulmonary mucus. Human rhinoviruses (HRVs) are by far the most common cause of symptomatic upper respiratory tract infection (URI) in people and are more recently appreciated as a significant cause of LRI. RSV and HRV are also implicated in asthma pathogenesis. Within both RSV and HRV, viral genetic differences play a role in disease severity and/or prevalence in patient populations, and viral genetic differences affect pathogenesis. Here, we review data on how viral genetic differences impact disease using RSV and HRV as examples, including effects on the host immune response. Virus genotype–phenotype relationships can be exploited in the laboratory to gain insight into mechanisms by which respiratory viruses modulate host immune responses and cause disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Working model of RSV strain-specific induction of airway mucin expression. (A) Electron micrograph of RSV exhibiting glycoprotein spikes. The sample was cell-free supernatant from RSV A2-infected primary human airway epithelial cells processed for negative staining. The RSV fusion (F) protein is a major spike protein necessary for virus fusion to target cells and for cell-cell fusion in the formation of syncytia. Recent work showed the “mucogenic” strain 2-20 F protein is capable of enhanced fusion compared to the laboratory A2 strain F protein [•43]. (B) Enhanced fusion correlates with the ability to infect the mouse airway epithelium. RSV strain 2-20 infects the BALB/c mouse airway epithelium, resulting in early necrotic cell debris in the airways as well as lung neutrophils [42, •43]. (C) Six days post-infection witih mucogenic RSV 2-20, IL-13-expressing CD4+ T cells are found in the lung [•43]. IL-13 plays a critical role in airway mucin induction by both RSV strains line 19 and 2-20 [35, 42]. (D) Robust PAS+ airways day 8 post-infection in lungs of a mouse infected with RSV 2-20. Digitized H&E-stained section as described [42]. Depletion of neutrophils results in signficantly fewer IL-13-expressing CD4+ T cells in the lung and less airway mucin expression, although the mechanism by which neutrophils promote TH2 cytokine expression and mucus are unknown.

Similar articles

Cited by

References

    1. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007;3:1414–1421. - PMC - PubMed
    1. Tumpey TM, Garcia-Sastre A, Mikulasova A, Taubenberger JK, Swayne DE, Palese P, Basler CF. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. PNAS. 2002;99:13849–13854. - PMC - PubMed
    1. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol. 2005;79:14933–14944. - PMC - PubMed
    1. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008;455:532–536. - PMC - PubMed
    1. Sauter D, Schindler M, Specht A, Landford WN, Munch J, Kim KA, Votteler J, Schubert U, Bibollet-Ruche F, Keele BF, et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe. 2009;6:409–421. - PMC - PubMed

Publication types

Substances